The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

XRAY FINANCIAL STATEMENTS

Dentsply Sirona Inc — balance sheet, income statement and cash flow trends

XRAYDentsply Sirona Inc

🇺🇸 USA · NASDAQ · Healthcare · Medical Instruments & Supplies

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
02 B4 B202020212022202420252026

Profit Funnel

Q2 2026 · TTM
Revenue3.6 B $Gross Profit1.8 B $ · 50%Operating Income426 M $ · 12%Pre-tax Income-347 M $ · -10%Net Income to Owners-546 M $ · -15%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue3.6 B $-0.8%
Gross Profit1.8 B $-4.9%
Operating Income426 M $—
EBITDA172 M $—
Net Income to Owners-546 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
05 B202020212022202420252026

Capital Structure

Q2 2026
Total Assets5.2 B
  • Equity1.4 B $26%
  • Current Liabilities1.2 B $23%
  • Long-term Liabilities2.7 B $51%

Key Figures

YoY change
Total Assets5.2 B $-14.3%
Total Liabilities3.9 B $-6.2%
Total Equity1.4 B $-31.1%
Cash & ST Investments239 M $-33.4%
Total Debt2.3 B $-7.3%
Net Debt2.1 B $-2.9%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0250 M500 M750 M202020212022202420252026

Cash Flow Bridge

Q2 2026 · TTM
0200 M319 M $Operating-173 M $Investing-265 M $Financing-119 M $Net Change

Key Figures

YoY change
Operating Cash Flow319 M $+12.7%
Capital Expenditures176 M $+21.4%
Free Cash Flow143 M $+3.6%
Dividends Paid128 M $+0.0%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on XRAY

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.